Search results for: Healthcare Systems
Filter search results
OHE Annual Lecture 2018: Is There an Economic Case for Investing in the NHS? Really?
3 September 2018, 11:00pm
…is a widely held view – particularly in finance ministries and some sections of the media – that health systems such as the NHS are ‘black holes’, constantly demanding increased…
OHE Lunchtime Seminar: Early Experience with HTA of Gene Therapies in the US: Pricing and Paying for Cures
21 October 2018, 11:00pm
…systems around the world must be able to manage a growing number of drugs offering potential cures for a wide range of illnesses. The innovation pipeline includes potential cures for…
Global rare‑disease policy shifts: what are the implications for equitable access to orphan medicines?
1 March 2026
…developments in the UK, EU, and US that impact this. The status quo: inequities across health systems The US and EU established regulatory incentives are linked to the granting of…
Prof Devlin Elected Chair of EuroQol Group
25 November 2010
…health care systems in dozens of countries. EuroQol Group members include leading researchers from around the world with expertise in a range of fields, including health economics, psychology and various clinical…
Health Technology Assessment of Gene Therapies: Are Our Methods Fit for Purpose?
1 June 2022
…benefits for society and health systems. Share this: Download publication Gene therapy is particularly relevant to rare disease patients, as more than 80 per cent of rare diseases have a…
Measuring Value with Pharmacoeconomics
26 May 2011
…may make sense only in health care systems with a “hard” budget constraint. no matter how well CEAs are conducted, uncertainty always will exist about the estimates. The use of…
What NHS Trusts Can Do to Reduce Waiting Times for Cancer Treatment
2 January 2020
The NHS Improvement Economics team is part of the Strategy Directorate in NHS Improvement. NHS Improvement aims to implement changes to help improve both quality and efficiency. Recent research by…
HTA and Payment Mechanisms for New Drugs to Tackle AMR
1 September 2019
Antimicrobial resistance (AMR) is a growing public health threat, limiting the ability of health care systems to prevent and treat infections and save lives. In parallel, global antibiotic development pipelines…
OHE in the Spotlight: Summer 2011
22 September 2011
…in emerging market health care systems. With Lou Garrison of University of Washington, Adrian Towse presented at the Industry HTA Learnings session on progress on the HTA emerging markets project…